| Tenofovir-based preexposure prophylaxis for HIV infection among African women JM Marrazzo, G Ramjee, BA Richardson, K Gomez, N Mgodi, G Nair, ... New England Journal of Medicine 372 (6), 509-518, 2015 | 1487 | 2015 |
| Timing of initiation of antiretroviral drugs during tuberculosis therapy SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ... New England Journal of Medicine 362 (8), 697-706, 2010 | 920 | 2010 |
| Use of a vaginal ring containing dapivirine for HIV-1 prevention in women JM Baeten, T Palanee-Phillips, ER Brown, K Schwartz, LE Soto-Torres, ... New England Journal of Medicine 375 (22), 2121-2132, 2016 | 859 | 2016 |
| Integration of antiretroviral therapy with tuberculosis treatment SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, AL Gray, ... New England Journal of Medicine 365 (16), 1492-1501, 2011 | 646 | 2011 |
| Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003) J Marrazzo, G Ramjee, G Nair, T Palanee, B Mkhize, C Nakabiito, ... 20th Conference on Retroviruses and Opportunistic infections, 3-6, 2013 | 350 | 2013 |
| Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial S Delany-Moretlwe, JP Hughes, P Bock, SG Ouma, P Hunidzarira, ... The Lancet 399 (10337), 1779-1789, 2022 | 290 | 2022 |
| HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised … K Ahmed, JM Baeten, M Beksinska, LG Bekker, EA Bukusi, D Donnell, ... The Lancet 394 (10195), 303-313, 2019 | 209 | 2019 |
| An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women JE Balkus, E Brown, T Palanee, G Nair, Z Gafoor, J Zhang, BA Richardson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 72 (3), 333-343, 2016 | 160 | 2016 |
| The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial K Naidoo, N Yende-Zuma, N Padayatchi, K Naidoo, N Jithoo, G Nair, ... Annals of internal medicine 157 (5), 313-324, 2012 | 150 | 2012 |
| Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo, DW Szydlo, ... The lancet HIV 8 (2), e87-e95, 2021 | 84 | 2021 |
| Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study LM Noguchi, BA Richardson, JM Baeten, SL Hillier, JE Balkus, ... The lancet HIV 2 (7), e279-e287, 2015 | 60 | 2015 |
| Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084. SD Moretlwe, J Hughes, P Bock, S Gurrion, P Hunidzarira, D Kalonji, ... Journal of the International AIDS Society 24 (S1), 8-9, 2021 | 58 | 2021 |
| Initiating ART during TB treatment significantly increases survival: results of a randomized controlled clinical trial in TB/HIV-co-infected patients in South Africa SA Karim, K Naidoo, A Grobler, N Padayatchi, G Nair, S Bamber, ... 16th Conference on Retroviruses and Opportunistic infections, 8-11, 2009 | 57 | 2009 |
| Age-disparate partnerships and risk of HIV-1 acquisition among South African women participating in the VOICE trial JE Balkus, G Nair, ET Montgomery, A Mishra, T Palanee-Phillips, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (2), 212-217, 2015 | 51 | 2015 |
| Characterization of human immunodeficiency virus (HIV) infections in women who received injectable cabotegravir or tenofovir disoproxil fumarate/emtricitabine for HIV … SH Eshleman, JM Fogel, E Piwowar-Manning, G Chau, V Cummings, ... The Journal of infectious diseases 225 (10), 1741-1749, 2022 | 46 | 2022 |
| Impact of male partner involvement on women’s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial ST Roberts, G Nair, JM Baeten, T Palanee-Philips, K Schwartz, K Reddy, ... AIDS and Behavior 24, 1432-1442, 2020 | 43 | 2020 |
| Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a phase III trial T Palanee-Phillips, ST Roberts, K Reddy, V Govender, L Naidoo, S Siva, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (5), 580-589, 2018 | 40 | 2018 |
| Characteristics of women enrolled into a randomized clinical trial of dapivirine vaginal ring for HIV-1 prevention T Palanee-Phillips, K Schwartz, ER Brown, V Govender, N Mgodi, ... PloS one 10 (6), e0128857, 2015 | 34 | 2015 |
| High adherence and sustained impact on HIV-1 incidence: final results of an open-label extension trial of the dapivirine vaginal ring JM Baeten, T Palanee-Phillips, N Mgodi, G Ramjee, B Gati, F Mhlanga, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 22, 29-29, 2019 | 27 | 2019 |
| Changes to antiretroviral drug regimens during integrated TB–HIV treatment: results of the SAPiT trial A Naidoo, K Naidoo, N Yende-Zuma, TN Gengiah, N Padayatchi, AL Gray, ... Antiviral therapy 19 (2), 161-169, 2014 | 27 | 2014 |
